Shareholders' equity · 2016–2025

10x Genomics shareholders' equity

$796M+12.1% · FY2025

10x Genomics (TXG) reported $796M in shareholders' equity for fiscal 2025, +12.1% year on year.

−$96.4M2016−$113M2017−$220M2018$420M2019$739M2020$818M2021$806M2022$741M2023$710M2024$796M2025
10x Genomics — Shareholders' equity, 2016–2025
Fiscal yearShareholders' equityChangeFiling
FY20252025-12-31$796M+12.1%Open →
FY20242024-12-31$710M−4.2%Open →
FY20232023-12-31$741M−8.0%Open →
FY20222022-12-31$806M−1.4%Open →
FY20212021-12-31$818M+10.6%Open →
FY20202020-12-31$739M+75.9%Open →
FY20192019-12-31$420M+$640MOpen →
FY20182018-12-31−$220M−$107MOpen →
FY20172017-12-31−$113M−$16.1MOpen →
FY20162016-12-31−$96.4M—Open →

Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026

Shareholders' equity at companies of similar size

Full ranking by shareholders' equity →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=10x Genomics shareholders' equity |url=https://companiesranked.com/en/company/10x-genomics/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). 10x Genomics shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/10x-genomics/shareholders-equity

BibTeX

@misc{companiesranked-en-company-10x-genomics-shareholders-equity-2026,
  author       = {{CompaniesRanked}},
  title        = {{10x Genomics shareholders' equity}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/10x-genomics/shareholders-equity}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001628280-26-054491 · August 7, 2026

{{cite web |title=10x Genomics shareholders' equity — 10-Q (0001628280-26-054491) |url=https://www.sec.gov/Archives/edgar/data/1770787/000162828026054491/txg-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-07}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← 10x Genomics overview